Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

2,765

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

June 30, 2006

Conditions
Urinary Incontinence, Stress
Interventions
DRUG

Duloxetine Hydrochloride

DRUG

placebo

Trial Locations (1)

KT24 6QT

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Surrey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY